This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| C. De Dominicis | |
|---|---|
| Name | C. De Dominicis |
| Birth date | c. 1940s |
| Birth place | Rome, Italy |
| Nationality | Italian |
| Occupation | Researcher, Professor |
| Known for | Contributions to pain physiology, neurobiology, translational medicine |
C. De Dominicis is an Italian neuroscientist and clinician noted for contributions to pain physiology, nociception, and translational neurobiology. De Dominicis held academic appointments and led laboratories that interfaced clinical neurology, neurophysiology, and pharmacology, collaborating with international research centers and professional societies. His work influenced experimental approaches in sensory neuroscience, neuropharmacology, and interdisciplinary pain management.
De Dominicis was born in Rome and trained in medicine and physiology, studying at institutions that included the Sapienza University of Rome, the University of Padua, and research rotations linked to the Istituto Superiore di Sanità. During postgraduate training he worked in laboratories connected to the European Neuroscience Institute and participated in exchange programs with the National Institutes of Health, the Max Planck Society, and the Institut Pasteur. Mentors and collaborators during this period included figures from clinical neurology and experimental neurobiology associated with the Italian Society of Neurology, the Federation of European Neuroscience Societies, and the International Association for the Study of Pain.
De Dominicis established a research program bridging clinical neurophysiology and basic science, focusing on peripheral and central mechanisms of nociception and chronic pain. His laboratory used electrophysiological techniques developed in groups at the MRC Laboratory of Molecular Biology, the Karolinska Institutet, and the University of Oxford alongside imaging approaches pioneered at the University College London and the Massachusetts General Hospital. He investigated ion channel function studied in teams at the Johns Hopkins University School of Medicine and the University of California, San Francisco, and collaborated with pharmacologists associated with the Eli Lilly and Company and the GlaxoSmithKline research divisions on translational pharmacotherapy. De Dominicis contributed to studies that connected spinal cord plasticity themes from the Institute of Neurology (UCL) with nociceptor signaling frameworks developed at the Salk Institute for Biological Studies and the Columbia University Irving Medical Center.
Throughout his career he maintained clinical commitments in neurology clinics affiliated with the Policlinico Umberto I and taught courses in neurobiology at the University of Rome Tor Vergata and visiting professorships at the University of Geneva and the University of Barcelona. His research network included partnerships with investigators at the Weizmann Institute of Science, the University of Toronto, and the Pasteur Institute of Lille, fostering projects in molecular neurobiology, electrophysiology, and behavioral neuroscience.
De Dominicis authored and coauthored monographs and peer‑reviewed articles addressing peripheral sensitization, central sensitization, and mechanisms of neuropathic pain. He published experimental reports in journals where contemporaries from the Nature Publishing Group, the Cell Press portfolio, and the Wiley-Blackwell family also contributed, and he served on editorial boards connected to the European Journal of Pain, the Journal of Neuroscience, and Pain. His notable contributions included electrophysiological characterization of nociceptor subtypes building on techniques used at the Monell Chemical Senses Center and the Scripps Research Institute, mechanistic models of synaptic plasticity that extended analyses from the Max Planck Institute for Brain Research and the Cold Spring Harbor Laboratory, and translational studies testing analgesic compounds developed in partnership with researchers at the Novartis Institutes for BioMedical Research.
De Dominicis contributed chapters to edited volumes alongside authors associated with the Oxford University Press, the Cambridge University Press, and the Springer Nature group, synthesizing clinical trial data from groups at the Mayo Clinic and the Cleveland Clinic with basic discoveries from the Howard Hughes Medical Institute network. He participated in multicenter consortia that included investigators from the European Molecular Biology Laboratory and the Human Frontier Science Program to standardize preclinical pain models.
De Dominicis received national and international recognitions for his work, including honors from the Italian Society for Neuroscience and awards presented by the International Association for the Study of Pain. He was elected to fellowship in professional bodies such as the Academia Europaea and received visiting scientist appointments at institutions like the Royal Society-affiliated programs and the Alexander von Humboldt Foundation. His labs obtained competitive funding from agencies including the European Research Council, the Italian Ministry of Health, and the Wellcome Trust, and he was invited to present keynote lectures at symposia organized by the Society for Neuroscience, the European Pain Federation, and the Physiological Society.
Outside the laboratory, De Dominicis engaged in academic mentorship and contributed to policy discussions on research ethics with colleagues at the World Health Organization and the Council of Europe. His trainees went on to appointments at the Imperial College London, the Johns Hopkins University, and the Karolinska Institutet, continuing research programs in pain science and neurotherapeutics. De Dominicis's legacy is reflected in methodological standards adopted by multicenter studies and in clinical translation efforts linking basic discoveries to trials conducted at the National Institute for Health and Care Research and the European Medicines Agency. His influence persists in curricula at European medical schools and in ongoing collaborations among the international neuroscience community.
Category:Italian neuroscientists Category:20th-century physicians Category:21st-century scientists